Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - FREE CASH FLOW
Free Cash Flow RARE - Ultragenyx Pharmaceutical Inc.
-522 M
LAST VALUE
-12.54%
2 YEAR CAGR
-12.10%
5 YEAR CAGR
-32.36%
10 YEAR CAGR